1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Izana Bioscience Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Namilumab for Moderate-to-severe Axial Spondyloarthritis Placebo, Namilumab - Axial Spondyloarthritis | Phase 2 | Completed | Izana Bioscience Ltd. | 42 | 2018-09-06 | 2022-03-08 |
namilumab (1)
United Kingdom (1)